Free tool
Drugs in development
Last checked: Nov 20, 2026Latest source record: rebuilt Nov 18, 2026Source: ClinicalTrials.govMethods & limitations
Drugs in development
3,685
Not FDA-approved
In Phase 3
1,424
Highest phase reached
Matching your filters
267
267 drugs in development
Names, sponsors and conditions come from the trial records. Click a drug for its trials.
- paridiprubartPhase 22 trials
PPD Development, LP · Acute Respiratory Distress Syndrome (ARDS), ARDS, ARDS (Acute Respiratory Distress Syndrome)
- PGN-EDODM1Phase 22 trials
PepGen Inc · Myotonic Dystrophy 1
- ProgerininPhase 22 trials
PRG Science & Technology Co., Ltd. · Werner Syndrome, Hutchinson-Gilford Progeria Syndrome
- R2R01Phase 22 trials
River 2 Renal Corp. · Acute Kidney Injury, Hepatorenal Syndrome
- R3R01Phase 22 trials
River 3 Renal Corp. · Diabetic Kidney Disease, Alport Syndrome, Focal Segmental Glomerulosclerosis
- REGN7544baloncibartPhase 22 trials
Regeneron · Postural Orthostatic Tachycardia Syndrome (POTS), Sepsis-Induced Hypotension
- rhu-pGSNrecombinant human gelsolin, Recombinant human plasma gelsolin pre-exposurePhase 22 trials
BioAegis Therapeutics Inc. · Acute Respiratory Distress Syndrome, Infections, Decompression Sickness
- rivogenlecleucelBPX-501 T cells, BPX-501Phase 22 trials
Bellicum Pharmaceuticals · Acute Lymphoblastic Leukemia, Myelodysplastic Syndromes, Leukemia, Acute Myeloid (AML), Child
- SAR447537Phase 22 trials
Sanofi · Alpha 1-Antitrypsin Deficiency, Emphysema
- SAT-3247Phase 22 trials
Satellos Bioscience, Inc. · Duchenne Muscular Dystrophy, Duchenne, DMD
- TebapivatAG-946Phase 22 trials
Agios Pharmaceuticals, Inc. · Myelodysplastic Syndromes, Sickle Cell Disease
- TTI-0102cysteamine-pantetheine disulfidePhase 22 trials
Thiogenesis Therapeutics, Inc. · Nephropathic Cystinosis, Cystinosis, MELAS Syndrome
- vilobelimabPhase 22 trials
PPD Development, LP · Acute Respiratory Distress Syndrome (ARDS), ARDS, ARDS (Acute Respiratory Distress Syndrome)
- VNX001Phase 22 trials
Vaneltix Pharma, Inc. · Interstitial Cystitis, Bladder Pain Syndrome
- VX-670Phase 22 trials
Vertex Pharmaceuticals · Myotonic Dystrophy Type 1 (DM1)
- WVE-N531Phase 22 trials
Wave Life Sciences USA, Inc. · Duchenne Muscular Dystrophy
- AAVB-081Phase 21 trial
AAVantgarde Bio Srl · Usher Syndrome, Type 1B
- AB8939Phase 21 trial
AB Science · Acute Myeloid Leukemia Refractory, Acute Myeloid Leukemia, in Relapse, Myelodysplastic Syndrome Acute Myeloid Leukemia
- ABD-3001DIMATEPhase 21 trial
Advanced BioDesign · Acute Myeloid Leukemia, Adult, Myelodysplastic Syndromes
- ACDN-01Phase 21 trial
Ascidian Therapeutics, Inc · Stargardt Disease, Cone Rod Dystrophy, Juvenile Macular Degeneration
- ALT-100Phase 21 trial
Aqualung Therapeutics Corp. · Acute Respiratory Distress Syndrome (ARDS)
- AMT-191Phase 21 trial
UniQure Biopharma B.V. · Fabry Disease
- AMXI-5001Phase 21 trial
AtlasMedx, Incorporated · Advanced Malignant Neoplasm, Breast Cancer, Ovarian Cancer
- ARCT-810Phase 21 trial
Arcturus Therapeutics, Inc. · OTC Deficiency, Ornithine Transcarbamylase Deficiency, OTCD
- ARD103Phase 21 trial
ARCE Therapeutics, Inc. · Acute Myeloid Leukemia, in Relapse, Acute Myeloid Leukemia Refractory, MDS (Myelodysplastic Syndrome)
- AT02Phase 21 trial
Attralus, Inc. · Amyloidosis; Systemic
- ATR 1072Phase 21 trial
Atrium Therapeutics · Cardiac Glycogenosis, Cardiomyopathy, Hypertrophic
- ATSN-101Phase 21 trial
Atsena Therapeutics Inc. · Leber Congenital Amaurosis, LCA, LCA1
- ATV-1601Phase 21 trial
Atavistik Bio, Inc · Hereditary Hemorrhagic Telangiectasia (HHT), Osler Weber Rendu Disease
- ATX-01Phase 21 trial
ARTHEx Biotech S.L. · Myotonic Dystrophy 1
- AV-001Phase 21 trial
Vasomune Therapeutics, Inc. · Acute Respiratory Distress Syndrome, Viral or Bacterial Infections, Pneumonia
- AZD3632Phase 21 trial
AstraZeneca · Acute Lymphoblastic Leukaemia, Acute Myeloid Leukaemia, Higher-risk Myelodysplastic Syndromes
- BAY 3401016Phase 21 trial
Bayer · Alport Syndrome
- BBI-001Phase 21 trial
Bond Biosciences · Hereditary Hemochromatosis
- BEAM-302Phase 21 trial
Beam Therapeutics Inc. · Alpha 1-Antitrypsin Deficiency
- BFB-101AAV9-CBh-AP4B1Phase 21 trial
BlackfinBio Ltd · HSP, Hereditary Spastic Paraplegia, Hereditary Spastic Paraparesis
- BMN 307Phase 21 trial
BioMarin · Phenylketonuria (PKU)
- BW-20805Phase 21 trial
Shanghai Argo Biopharmaceutical Co., Ltd. · Hereditary Angioedema (HAE)
- CFI-400945Phase 21 trial
Treadwell Therapeutics, Inc · Acute Myeloid Leukemia, Myelodysplastic Syndromes, Chronic Myelomonocytic Leukemia
- CLN-049Phase 21 trial
Cullinan Therapeutics Inc. · Relapsed/Refractory Acute Myeloid Leukemia (AML), Myelodysplastic Syndrome (MDS), TP53-mutated MDS and AML
- Combination of NavepegritidePhase 21 trial
Ascendis Pharma Growth Disorders A/S · Achondroplasia
- CSTI-500Phase 21 trial
ConSynance Therapeutics · Prader-Willi Syndrome
- CTH120Phase 21 trial
Connecta Therapeutics, S.L. · Fragile X Syndrome (FXS), Fragile X Syndrome
- CTO1681Phase 21 trial
CytoAgents, Inc. · Cytokine Release Syndrome
- CTX-712Phase 21 trial
Chordia Therapeutics, Inc. · Acute Myeloid Leukemia, Myelodysplastic Syndromes
- CTX460Phase 21 trial
CRISPR Therapeutics · Alpha-1 Antitrypsin Deficiency (AATD)
- DIAG723Phase 21 trial
Diagonal Therapeutics, Inc. · Hereditary Hemorrhagic Telangiectasia, Pulmonary Arterial Hypertension
- DNL126Phase 21 trial
Denali Therapeutics Inc. · Mucopolysaccharidosis Type IIIA
- DNL952Phase 21 trial
Denali Therapeutics Inc. · Late-onset Pompe Disease
- DT-168Phase 21 trial
Design Therapeutics, Inc. · Fuchs Endothelial Corneal Dystrophy, Fuchs
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.